Summary of Q&A for Results Briefing of the 3rd Quarter of Fiscal Year 2022 held on February 3, 2023
February 3, 2023
You haven't changed your full-year consolidated earning forecast. Please tell us your outlook for the fourth quarter. Do you have any concerns other than the decreasing factor by sales of shares of Nissui Pharmaceutical Co., Ltd?
In the fisheries business, business performance in North America is recovering. Could you tell us if you think that this profit level will continue in the future?
Regarding the cost increases and price increases in the food business, please explain why the effect of the Japan price increase is less (8.4 billion) than the November forecast (9.5 billion). Also, could you tell us whether the price increase from February to March will cover the increased costs?
Regarding costs and price increases, please describe your prospects for the next fiscal year quantitatively.
It seems that the decrease in profit in the fine chemicals business is more than the decrease in profit due to the degroup of Nissui Pharmaceutical. Please tell us about the factors of the decline in profit other than the sale of Nissui Pharmaceutical.